Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Kynam Capital Management, LP Stock Portfolio

$1.30Billion– No. of Holdings #22

Kynam Capital Management, LP Performance:
2024 Q2: -1.77%YTD: 21.21%2023: 4.66%

Performance for 2024 Q2 is -1.77%, and YTD is 21.21%, and 2023 is 4.66%.

About Kynam Capital Management, LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Kynam Capital Management, LP reported an equity portfolio of $1.3 Billions as of 30 Jun, 2024.

The top stock holdings of Kynam Capital Management, LP are NTRA, CLDX, SNDX. The fund has invested 16.8% of it's portfolio in NATERA INC and 9.7% of portfolio in CELLDEX THERAPEUTICS INC NEW.

The fund managers got completely rid off BURNING ROCK BIOTECH LTD (BNR) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA) and PROTAGONIST THERAPEUTICS INC (PTGX). Kynam Capital Management, LP opened new stock positions in BURNING ROCK BIOTECH LTD (BNR) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), ACELYRIN INC and DYNAVAX TECHNOLOGIES CORP (DVAX).
Kynam Capital Management, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Kynam Capital Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Kynam Capital Management, LP made a return of -1.77% in the last quarter. In trailing 12 months, it's portfolio return was 25.84%.

New Buys

Ticker$ Bought
burning rock biotech ltd6,283,880
cg oncology inc1,701,970

New stocks bought by Kynam Capital Management, LP

Additions

Ticker% Inc.
viridian therapeutics inc1,207
acelyrin inc109
dynavax technologies corp67.05
caribou biosciences inc54.11
biocryst pharmaceuticals inc35.22
celldex therapeutics inc new16.86
tyra biosciences inc10.00
cogent biosciences inc8.95

Additions to existing portfolio by Kynam Capital Management, LP

Reductions

Ticker% Reduced
liquidia corporation-59.23
protagonist therapeutics inc-30.08

Kynam Capital Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
burning rock biotech ltd-7,019,550

Kynam Capital Management, LP got rid off the above stocks

Sector Distribution

Kynam Capital Management, LP has about 98.8% of it's holdings in Healthcare sector.

Sector%
Healthcare98.8
Others1.2

Market Cap. Distribution

Kynam Capital Management, LP has about 22.8% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP43.9
MID-CAP27.8
LARGE-CAP22.8
MICRO-CAP4.2
UNALLOCATED1.2

Stocks belong to which Index?

About 75.1% of the stocks held by Kynam Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200075.1
Others24.9
Top 5 Winners (%)%
COGT
cogent biosciences inc
24.2 %
NTRA
natera inc
18.3 %
BCRX
biocryst pharmaceuticals inc
17.8 %
PTGX
protagonist therapeutics inc
13.1 %
PCVX
vaxcyte inc
10.6 %
Top 5 Winners ($)$
NTRA
natera inc
33.7 M
COGT
cogent biosciences inc
15.2 M
BCRX
biocryst pharmaceuticals inc
8.3 M
PCVX
vaxcyte inc
5.4 M
PTGX
protagonist therapeutics inc
4.3 M
Top 5 Losers (%)%
CRBU
caribou biosciences inc
-64.0 %
STRO
sutro biopharma inc
-48.0 %
TSVT
2seventy bio inc
-28.0 %
IRWD
ironwood pharmaceuticals inc
-25.0 %
AMRN
amarin corp plc
-22.7 %
Top 5 Losers ($)$
SNDX
syndax pharmaceuticals inc
-18.5 M
CLDX
celldex therapeutics inc new
-14.5 M
VERA
vera therapeutics inc
-10.6 M
TSVT
2seventy bio inc
-8.9 M
DVAX
dynavax technologies corp
-5.8 M

Kynam Capital Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Kynam Capital Management, LP

Kynam Capital Management, LP has 22 stocks in it's portfolio. About 64.5% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Kynam Capital Management, LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions